Bank Julius Baer & Co’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $9.98M | Buy |
53,783
+5,555
| +12% | +$1.03M | 0.03% | 187 |
|
2025
Q1 | $10.8M | Buy |
48,228
+647
| +1% | +$145K | 0.04% | 185 |
|
2024
Q4 | $8.95M | Buy |
47,581
+4,790
| +11% | +$901K | 0.03% | 211 |
|
2024
Q3 | $9.35M | Buy |
42,791
+6,399
| +18% | +$1.4M | 0.03% | 193 |
|
2024
Q2 | $6.83M | Sell |
36,392
-10,990
| -23% | -$2.06M | 0.03% | 173 |
|
2024
Q1 | $8.55M | Buy |
47,382
+5,639
| +14% | +$1.02M | 0.03% | 174 |
|
2023
Q4 | $6.47M | Buy |
41,743
+12,361
| +42% | +$1.92M | 0.03% | 193 |
|
2023
Q3 | $4.38M | Buy |
29,382
+1,299
| +5% | +$194K | 0.03% | 183 |
|
2023
Q2 | $3.78M | Sell |
28,083
-4,833
| -15% | -$651K | 0.02% | 189 |
|
2023
Q1 | $5.25M | Buy |
32,916
+1,011
| +3% | +$161K | 0.03% | 181 |
|
2022
Q4 | $5.16M | Sell |
31,905
-39
| -0.1% | -$6.3K | 0.04% | 181 |
|
2022
Q3 | $4.29M | Buy |
31,944
+1,766
| +6% | +$237K | 0.03% | 170 |
|
2022
Q2 | $4.62M | Buy |
30,178
+1,734
| +6% | +$266K | 0.03% | 173 |
|
2022
Q1 | $4.61M | Sell |
28,444
-6,982
| -20% | -$1.13M | 0.03% | 176 |
|
2021
Q4 | $4.8M | Buy |
35,426
+2,070
| +6% | +$280K | 0.03% | 205 |
|
2021
Q3 | $3.6M | Buy |
33,356
+17,323
| +108% | +$1.87M | 0.02% | 212 |
|
2021
Q2 | $1.81M | Buy |
16,033
+1,897
| +13% | +$214K | 0.01% | 294 |
|
2021
Q1 | $1.53M | Buy |
14,136
+16
| +0.1% | +$1.73K | 0.01% | 291 |
|
2020
Q4 | $1.51M | Buy |
14,120
+5,174
| +58% | +$554K | 0.01% | 290 |
|
2020
Q3 | $784K | Buy |
8,946
+413
| +5% | +$36.2K | 0.01% | 322 |
|
2020
Q2 | $836K | Buy |
8,533
+1,377
| +19% | +$135K | 0.01% | 296 |
|
2020
Q1 | $545K | Buy |
+7,156
| New | +$545K | 0.01% | 303 |
|